CA1201439A - Procede de preparation de nouveaux derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique - Google Patents

Procede de preparation de nouveaux derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique

Info

Publication number
CA1201439A
CA1201439A CA000413983A CA413983A CA1201439A CA 1201439 A CA1201439 A CA 1201439A CA 000413983 A CA000413983 A CA 000413983A CA 413983 A CA413983 A CA 413983A CA 1201439 A CA1201439 A CA 1201439A
Authority
CA
Canada
Prior art keywords
radical
formula
products
product
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000413983A
Other languages
English (en)
French (fr)
Inventor
Rene Heymes
Alain Bonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of CA1201439A publication Critical patent/CA1201439A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA000413983A 1981-10-23 1982-10-22 Procede de preparation de nouveaux derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique Expired CA1201439A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR81-19946 1981-10-23
FR8119946A FR2515182B1 (fr) 1981-10-23 1981-10-23 Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Publications (1)

Publication Number Publication Date
CA1201439A true CA1201439A (fr) 1986-03-04

Family

ID=9263337

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000413983A Expired CA1201439A (fr) 1981-10-23 1982-10-22 Procede de preparation de nouveaux derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique

Country Status (12)

Country Link
JP (2) JPS58135883A (en, 2012)
AT (1) AT382150B (en, 2012)
BE (1) BE894785A (en, 2012)
CA (1) CA1201439A (en, 2012)
CH (1) CH655317A5 (en, 2012)
DE (1) DE3239157C2 (en, 2012)
FR (1) FR2515182B1 (en, 2012)
GB (1) GB2111482B (en, 2012)
IT (1) IT1157233B (en, 2012)
LU (1) LU84434A1 (en, 2012)
NL (1) NL8204089A (en, 2012)
SE (2) SE461655B (en, 2012)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
MX7096E (es) * 1980-12-05 1987-06-19 Takeda Chemical Industries Ltd Metodo para preparacion de derivados de 2-oxoazetidina
US4673739A (en) * 1980-12-05 1987-06-16 Takeda Chemical Industries, Ltd. 4-carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
US4675397A (en) * 1980-12-05 1987-06-23 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
FR2558467B2 (fr) * 1981-10-23 1987-03-20 Roussel Uclaf Nouveau produit derive de l'acide 3-amino 2-oxo azetidine 1-sulfamique, son procede de preparation, son application comme medicament et un produit intermediaire necessaire a sa preparation
US4443374A (en) * 1982-02-01 1984-04-17 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
JPS59175490A (ja) * 1983-03-24 1984-10-04 Banyu Pharmaceut Co Ltd 2−オキソ−1−アゼチジンスルホン酸誘導体
JPS58208288A (ja) * 1982-05-31 1983-12-03 Banyu Pharmaceut Co Ltd 2−オキソ−1−アゼチジンスルホン酸誘導体
DE3377061D1 (en) * 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
DE3372768D1 (de) * 1982-06-03 1987-09-03 Hoffmann La Roche 1-sulfo-2-oxoazetidine derivatives
JPS5982359A (ja) * 1982-11-02 1984-05-12 Kanegafuchi Chem Ind Co Ltd 4(R)配位光学活性β−ラクタム化合物の製法
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
JPS59231086A (ja) * 1983-06-15 1984-12-25 Teikoku Hormone Mfg Co Ltd 4−メトキシエチル−2−アゼチジノン−1−スルホン酸誘導体
US4501697A (en) * 1983-06-17 1985-02-26 E. R. Squibb & Sons, Inc. 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts
JPS6097978A (ja) * 1983-10-31 1985-05-31 Otsuka Chem Co Ltd 3−アシルアミノ−4−メチル−2−アゼチジノン−1−スルホン酸誘導体,その製造方法および該誘導体を含有する薬剤
JPS60202882A (ja) * 1984-03-27 1985-10-14 Teikoku Hormone Mfg Co Ltd 新規な2−アゼチジノン−1−スルホン酸誘導体
US4837318A (en) * 1985-05-09 1989-06-06 The Upjohn Company Carbonate substituted monobactams as antibiotics
JPS62502825A (ja) * 1985-05-09 1987-11-12 ジ・アップジョン・カンパニ− 抗生物質としてのカ−ボネ−ト置換モノバクタム
DE19642530A1 (de) * 1996-10-15 1998-04-16 Bayer Ag Halogenalkoximinoessigsäureamide
US6677028B1 (en) 1999-09-10 2004-01-13 3M Innovative Properties Company Retroreflective articles having multilayer films and methods of manufacturing same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK194776A (da) * 1975-05-05 1976-11-06 Smithkline Corp Antibakterielle midler og mellemprodukter dertil
US4166816A (en) * 1975-05-05 1979-09-04 Smithkline Corporation Methods and intermediates for preparing cis-4-oxoazetidine intermediates
FR2361885A1 (fr) * 1975-09-03 1978-03-17 Smithkline Corp Analogues de la penicilline, leurs intermediaires et procedes pour leur obtention
US4103086A (en) 1975-10-29 1978-07-25 Smithkline Corporation 8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives
US4085100A (en) * 1976-11-01 1978-04-18 Smithkline Corporation Intermediate for dephthaloylation of azetidinone compounds
US4144333A (en) * 1976-11-15 1979-03-13 Smithkline Corporation Monocyclic beta-lactams with antibacterial activity
US4218459A (en) 1977-12-28 1980-08-19 Merck & Co., Inc. 6-Amido-1-carba-2-penem-3-carboxylic acid
US4218463A (en) 1977-12-28 1980-08-19 Merck & Co., Inc. 3-Substituted thio-6-amido-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
EP0005507A1 (de) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Fragmentierungsverfahren von 3-(2-Hydroxyimino-acetylamino)-2-oxo-azetidin-Verbindungen und die erhaltenen Verbindungen
DE3069587D1 (en) * 1979-06-08 1984-12-13 Takeda Chemical Industries Ltd 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
NZ205240A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Sulphonamide derivatives,being starting materials for producing beta-lactams
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS58189176A (ja) 1982-04-30 1983-11-04 Takeda Chem Ind Ltd 1−スルホ−2−アゼチジノン誘導体およびその製造法
JPS57131758A (en) * 1980-12-05 1982-08-14 Takeda Chem Ind Ltd 1-sulfo-2-oxoazetidine derivative, its preparation and use
JPS58210061A (ja) 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 1−スルホ−2−オキソアゼチジン誘導体、その製造法および用途
DE3274981D1 (en) * 1981-10-05 1987-02-12 Squibb & Sons Inc 4-ether derivatives of 2-azetidinone-1-sulfonic acids
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
JPS59175490A (ja) * 1983-03-24 1984-10-04 Banyu Pharmaceut Co Ltd 2−オキソ−1−アゼチジンスルホン酸誘導体
HU189290B (en) * 1982-05-31 1986-06-30 Banyu Pharmaceutical Co Ltd,Jp Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
JPS58208288A (ja) * 1982-05-31 1983-12-03 Banyu Pharmaceut Co Ltd 2−オキソ−1−アゼチジンスルホン酸誘導体

Also Published As

Publication number Publication date
DE3239157A1 (de) 1983-05-05
IT8249341A0 (it) 1982-10-22
JPH04234844A (ja) 1992-08-24
SE8205870D0 (sv) 1982-10-15
NL8204089A (nl) 1983-05-16
LU84434A1 (fr) 1983-06-13
SE461655B (sv) 1990-03-12
JPH0471073B2 (en, 2012) 1992-11-12
SE8205870L (sv) 1983-04-24
GB2111482B (en) 1985-11-06
JPH0730018B2 (ja) 1995-04-05
CH655317A5 (fr) 1986-04-15
DE3239157C2 (de) 1994-04-28
FR2515182B1 (fr) 1986-05-09
FR2515182A1 (fr) 1983-04-29
ATA391182A (de) 1986-06-15
IT1157233B (it) 1987-02-11
JPS58135883A (ja) 1983-08-12
AT382150B (de) 1987-01-12
SE500849C2 (sv) 1994-09-19
SE8702330D0 (sv) 1987-06-04
BE894785A (fr) 1983-04-22
SE8702330L (sv) 1987-06-04
GB2111482A (en) 1983-07-06

Similar Documents

Publication Publication Date Title
CA1201439A (fr) Procede de preparation de nouveaux derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique
CA1125280A (fr) Procede de preparation de nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique
CH622800A5 (en, 2012)
EP0034536A2 (fr) Nouvelles oximes dérivées de l'acide 3-alkyloxy ou 3-alkylthiométhyl 7-amino thiazolylacétamido céphalosporanique, leur préparation, leur application comme médicaments et les compositions les renfermant
CH622264A5 (en) Process for the preparation of new oximes, syn isomers, derived from 7-(aminothiazolylacetamido)cephalosporanic acid
EP0088853B1 (fr) Nouveaux dérivés de pyridinium thiométhyl céphalosporines, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0001193B1 (fr) Amino-acides cycliques, leurs procédés d'obtention et compositions pharmaceutiques les contenant
LU82352A1 (fr) 7-(2-(2-amino-4-thiazolyl)-2-((1-carboxy-1,1-dialkyl)alcoxy-imino)acetamido)cephem sulfoxydes a action antibacterienne
FR2472574A1 (fr) Derives de cephalosporine et composition pharmaceutique les contenant
CA1244034A (fr) Procede pour la preparation de derives de la 3-amino 2-oxo-azetidine comportant en position 1 un radical heterocyclique azote, et les derives ainsi obtenus
CA1315274C (fr) Procede de preparation de nouvelles oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique
CH629815A5 (en) Oximes derived from 7-(aminothiazolylacetamido)cephalosporanic acid, process of preparation and pharmaceutical compositions
CA1194873A (fr) Procede de preparation de nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique
CA1148937A (fr) Procede de preparation de nouvelles aco-yloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl) acetamido cephalosporanique
CH639388A5 (fr) Cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl) 2-(carboxymethoxyimino) acetamido/ 3-substitue cephalosporanique, leurs procedes de preparation et medicaments les renfermant.
CH626088A5 (en) Process for the preparation of new oximes derived from 3-carbamoyloxymethyl-7-(aminothiazolylacetamido)cephalosporanic acid
CA1152061A (fr) Procede de preparation de nouvelles oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique
FR2556721A1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
CH633016A5 (en) Oximes derived from 3-(thiadiazolylthiomethyl)-7-(aminothiazolylacetamido)cephalosporanic acid, process of preparation and pharmaceutical compositions
CH640858A5 (fr) Oximes derivees de l'acide 3-azidomethyl 7-amino thiazolyl acetamido cephalosporanique, leurs procedes de preparation et les medicaments les renfermant.
CH668073A5 (fr) Acides beta-lactame hydroxamiques o-sulfates.
FR2588867A1 (fr) Nouveaux produits derives de la serie de la 3-amino 2-oxo azetidine, leur procede de preparation et leur application
EP0176444A1 (fr) Nouveau procédé de préparation de dérivés du 4 H-1,2-4-triazole, nouveaux triazoles ainsi obtenus, leur applicication comme médicaments et les compositions pharmaceutiques les renfermant
CH643267A5 (fr) Oximes de l'acide 7-amino thiazolyl acetamido cephalosporanique, leurs procedes de preparation et les medicaments les renfermant.
LU84142A1 (fr) Esters 2-methoxyphenyliques d'amino-acides n-substitues,procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
MKEX Expiry